Bridging innate NK cell functions with adaptive immunity

Advances in Experimental Medicine and Biology

Volumn 780, Issue , 2011, Pages 45-55

  Marcenaro, Emanuela ^a   Carlomagno, Simona ^a   Pesce, Silvia ^a   Moretta, Alessandro ^a   Sivori, Simona ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; NATURAL KILLER CELL RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CELL CLONE; CELL FUNCTION; CELL INTERACTION; CELL KILLING; CELL MIGRATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOSOME; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INNATE IMMUNITY; INTERNALIZATION; LYMPH NODE; LYMPHOID TISSUE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RECIPIENT; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; CELL COMMUNICATION; CELL MOVEMENT; CHEMOKINE CCL19; CHEMOKINE CCL21; DENDRITIC CELLS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPH NODES; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CCR7; RECEPTORS, KIR; TOLL-LIKE RECEPTOR 9; TRANSPLANTATION, ISOGENEIC;

EID: 80053585264     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5632-3_5     Document Type: Conference Paper

References (69)

1. Moretta A, Bottino C, Vitale M et al (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619-648 (Pubitemid 26130196)
2. Braud VM, Allan DS, O'Callaghan CA et al (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799 (Pubitemid 28099678)
3. Moretta A, Bottino C, Vitale M et al (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197-223 (Pubitemid 32368034)
4. Moretta L, Biassoni R, Bottino C et al (2000) Human NK-cell receptors. Immunol Today 21:420-422
5. Bottino C, Falco M, Parolini S et al (2001) NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J Exp Med 194:235-246 (Pubitemid 32730798)
6. Bottino C, Castriconi R, Moretta L et al (2005) Cellular ligands of activating NK receptors. Trends Immunol 26:221-226 (Pubitemid 41556860)
7. Raulet DH (2003) Roles of the NKG2D immuno-receptor and its ligands. Nat Rev Immunol 3:781-790 (Pubitemid 37328656)
8. Agaugue S, Marcenaro E, Ferranti B et al (2008) Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 112:1776-1783
9. Marcenaro E, Della Chiesa M, Bellora F et al (2005) IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J Immunol 174:3992-3998 (Pubitemid 40395974)
10. Marcenaro E, Ferranti B, Falco M et al (2008) Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol 20:1155-1167
11. Sivori S, Falco M, Della Chiesa M et al (2004) CpG and double-stranded RNA trigger human NK cells by toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101:10116-10121 (Pubitemid 38891204)
12. Colonna M, Samaridis J (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405-408
13. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359-393 (Pubitemid 28183369)
14. Moretta A, Vitale M, Bottino C et al (1993) P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med 178:597-604 (Pubitemid 23218208)
15. Moretta L, Moretta A (2004) Killer immunoglobulin-like receptors. Curr Opin Immunol 16:626-633 (Pubitemid 39165891)
16. Wagtmann N, Biassoni R, Cantoni C et al (1995) Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2:439-449
17. Biassoni R, Cantoni C, Falco M et al (1996) The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J Exp Med 183:645-650
18. Moretta A, Sivori S, Vitale M et al (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J Exp Med 182:875-884
19. Chewning JH, Gudme CN, Hsu KC et al (2007) KIR2DS1-positive NK cells mediate allore-sponse against the C2 HLA-KIR ligand group in vitro. J Immunol 179:854-868
20. Stewart CA, Laugier-Anfossi F, Vely F et al (2005) Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 102:13224-13229 (Pubitemid 41325005)
21. Vilches C, Parham P (2002) KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 20:217-251 (Pubitemid 34293425)
22. Bottino C, Sivori S, Vitale M et al (1996) A novel surface molecule homologous to the p58/ p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. Eur J Immunol 26:1816-1824 (Pubitemid 26283156)
23. Della Chiesa M, Romeo E, Falco M et al (2008) Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. Eur J Immunol 38:2284-2289
24. Estefania E, Flores R, Gomez-Lozano N et al (2007) Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J Immunol 178:4402-4410 (Pubitemid 46492391)
25. Kikuchi-Maki A, Yusa S, Catina TL et al (2003) KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production. J Immunol 171:3415-3425 (Pubitemid 37254542)
26. Thananchai H, Gillespie G, Martin MP et al (2007) Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178:33-37 (Pubitemid 46033585)
27. Dohring C, Scheidegger D, Samaridis J et al (1996) A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 156:3098-3101 (Pubitemid 26123520)
28. Pende D, Biassoni R, Cantoni C et al (1996) The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer. J Exp Med 184:505-518 (Pubitemid 26324104)
29. Litwin V, Gumperz J, Parham P et al (1994) NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J Exp Med 180:537-543 (Pubitemid 24224130)
30. Rajagopalan S, Bryceson YT, Kuppusamy SP et al (2006) Activation of NK cells by an endo-cytosed receptor for soluble HLA-G. PLoS Biol 4:e9
31. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244 (Pubitemid 20198988)
32. Anfossi N, Andre P, Guia S et al (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25:331-342 (Pubitemid 44224147)
33. Latz E, Schoenemeyer A, Visintin A et al (2004) TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5:190-198 (Pubitemid 38208361)
34. Leifer CA, Kennedy MN, Mazzoni A et al (2004) TLR9 is localized in the endoplasmic reticulum prior to stimulation. J Immunol 173:1179-1183 (Pubitemid 38924294)
35. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20:709-760 (Pubitemid 34293438)
36. Sanjuan MA, Rao N, Lai KT et al (2006) CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion. J Cell Biol 172:1057-1068
37. Sivori S, Falco M, Carlomagno S et al. (2010) A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 116:1637-1647
38. Khakoo SI, Geller R, Shin S et al (2002) The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J Exp Med 196:911-921
39. Wilson MJ, Torkar M, Haude A et al (2000) Plasticity in the organization and sequences of human KIR/ILT gene families. Proc Natl Acad Sci USA 97:4778-4783 (Pubitemid 30238634)
40. Fehniger TA, Cooper MA, Nuovo GJ et al (2003) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101:3052-3057 (Pubitemid 36857995)
41. Ferlazzo G, Thomas D, Lin SL et al (2004) The abundant NK cells in human secondary lym-phoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172:1455-1462 (Pubitemid 38116788)
42. Moser B, Loetscher P (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123-128 (Pubitemid 33707929)
43. Della Chiesa M, Vitale M, Carlomagno S et al (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33:1657-1666 (Pubitemid 36790427)
44. Della Chiesa M, Sivori S, Castriconi R et al (2005) Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol 13:128-136 (Pubitemid 40311895)
45. Moretta A (2002) Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2:957-964 (Pubitemid 37323216)
46. Moretta A, Marcenaro E, Parolini S et al (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15:226-233
47. Marcenaro E, Della Chiesa M, Pesce S et al (2009) The NK/DC complot. Adv Exp Med Biol 633:7-16
48. Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22:633-640 (Pubitemid 33043908)
49. Parolini S, Santoro A, Marcenaro E et al (2007) The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 109:3625-3632 (Pubitemid 46641708)
50. Robertson MJ (2002) Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71:173-183
51. Vitale M, Della Chiesa M, Carlomagno S et al (2004) The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 34:1715-1722 (Pubitemid 39256054)
52. Sallusto F, Mackay CR, Lanzavecchia A (2000) The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18:593-620 (Pubitemid 30365392)
53. Mailliard RB, Alber SM, Shen H et al (2005) IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 202:941-953
54. Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333-1339 (Pubitemid 38116773)
55. Ferlazzo G, Tsang ML, Moretta L et al (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343-351 (Pubitemid 34461492)
56. Gerosa F, Baldani-Guerra B, Nisii C et al (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327-333 (Pubitemid 34461490)
57. Piccioli D, Sbrana S, Melandri E et al (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195:335-341 (Pubitemid 34461491)
58. Bajenoff M, Glaichenhaus N, Germain RN (2008) Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. J Immunol 181:3947-3954
59. Marcenaro E, Cantoni C, Pesce S et al (2009) Uptake of CCR7 and acquisition of migratory properties by human KIR+NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 114:4108-4116
60. Davis DM (2007) Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat Rev Immunol 7:238-243
61. Hudrisier D, Riond J, Mazarguil H et al (2001) Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J Immunol 166: 3645-3649 (Pubitemid 32224883)
62. Joly E, Hudrisier D (2003) What is trogocytosis and what is its purpose?. Nat Immunol 4:815 (Pubitemid 37098646)
63. Mack M, Kleinschmidt A, Bruhl H et al (2000) Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6:769-775 (Pubitemid 30469425)
64. Tabiasco J, Espinosa E, Hudrisier D et al (2002) Active trans-synaptic capture of membrane fragments by natural killer cells. Eur J Immunol 32:1502-1508 (Pubitemid 34546279)
65. Moretta A, Bottino C, Pende D et al (1990) Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med 172:1589-1598
66. Moretta A, Locatelli F, Moretta L (2008) Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol Rev 224:58-69
67. Pende D, Marcenaro S, Falco M et al (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haplo-identical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113:3119-3129
68. Ruggeri L, Mancusi A, Capanni M et al (2007) Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. Blood 110:433-140
69. Velardi A, Ruggeri L, Moretta A et al (2002) NK cells: a lesson from mismatched hematopoi-etic transplantation. Trends Immunol 23:438-444 (Pubitemid 35015187)